Cancer Litigation over Zantac: US Court gives relief to pharma cos, dismisses thousands of lawsuits Ruchika Sharma7 Dec 2022 1:10 PM ISTA Sanofi spokesperson said the decision "significantly decreases the scope of the litigation potentially by over 50%," with the remaining litigation...
Britain regulator calls for review of reactions in eyes to Sanofi asthma drug Dupixent Ruchika Sharma30 Nov 2022 5:30 PM ISTEuropean and U.S. health regulators have listed conjunctivitis, an eye irritation that can cause redness and discomfort, as a side effect of Dupixent
Sanofi Dupixent recommended for EU approval by CHMP for prurigo nodularis treatment Ruchika Sharma13 Nov 2022 4:30 PM ISTDupixent is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not...
Sanofi gets European Commission nod for Beyfortus to prevent RSV disease in infants Ruchika Sharma5 Nov 2022 3:00 PM ISTRSV is the most common cause of LRTI, including bronchiolitis and pneumonia, in infants.
Sanofi forecasts faster profit growth on Dupixent, flu vaccine demand Ruchika Sharma30 Oct 2022 10:00 AM ISTParis: French drugmaker Sanofi on Friday forecasted faster earnings growth this year on strong demand for its bestselling drug Dupixent and for...
Sanofi, Provention Bio ink pact for launch of Diabetes drug Teplizumab Ruchika Sharma9 Oct 2022 4:00 PM ISTTeplizumab is an anti-CD3 monoclonal antibody that is being developed for the delay of clinical T1D in at-risk individuals, as indicated by the...
Sanofi expects positive boost from currency markets in Q3 Ruchika Sharma28 Sept 2022 4:34 PM ISTSanofi reports results denominated in the euro currency, and would therefore benefit from an increase in the value of the U.S dollar against the euro,...
EMA Committee recommends nod of Sanofi, AstraZeneca Beyfortus for prevention of RSV disease in infants Ruchika Sharma18 Sept 2022 3:00 PM ISTParis: Sanofi and AstraZeneca have recently announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has...
GSK, Sanofi see EU drugs regulator decision on COVID booster in weeks Ruchika Sharma6 Sept 2022 2:00 PM ISTThe vaccine could be used as a booster for people who had received any other COVID-19 vaccine, Triomphe said.
Sanofi gets USFDA nod for ASMD drug Xenpozyme Ruchika Sharma2 Sept 2022 3:57 PM ISTASMD, historically known as Niemann-Pick disease types A, A/B, and B, is an extremely rare, progressive genetic disease with significant morbidity and...
Sanofi stops breast cancer drug Amcenestrant Clinical Development Program Roshni Dhar19 Aug 2022 6:30 PM ISTPharma major, Sanofi, has announced the discontinuation of the global clinical development program of amcenestrant, an investigational oral selective...
Sanofi halts breast cancer drug Amcenestrant clinical development program Ruchika Sharma18 Aug 2022 1:15 PM ISTParis: Pharma major, Sanofi, has announced the discontinuation of the global clinical development program of amcenestrant, an investigational oral...
